New Laboratory Tool Opens Door to Better Treatments for Rare and Deadly Melanomas
This platform allows us, and research groups worldwide, to rationally design and test new immunotherapy combinations — something…
New drug Rapalink-1 slows cellular aging, study finds
A recent study conducted by researchers at Queen Mary University of London unveiled a new mechanism through which…